APTALIS PHARMA INC Interest and Debt Expense
APTALIS PHARMA INC reported Interest and Debt Expense of $22.10 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Expense Statement
us-gaap:InterestAndDebtExpense · last filed 2012-02-10
- APTALIS PHARMA INC interest and debt expense for the quarter ending 2011-12-31 was $22.10M, a 36.17% increase year-over-year.
- APTALIS PHARMA INC interest and debt expense for the quarter ending 2011-09-30 was $22.45M, a 38.89% increase year-over-year.
- APTALIS PHARMA INC interest and debt expense for the quarter ending 2011-06-30 was $20.67M, a 27.52% increase year-over-year.
- APTALIS PHARMA INC interest and debt expense for the quarter ending 2010-12-31 was $16.23M.
- APTALIS PHARMA INC interest and debt expense for fiscal 2011 was $89.50M, a 37.78% increase from fiscal 2010.
- APTALIS PHARMA INC interest and debt expense for fiscal 2010 was $64.96M, a 6.95% decline from fiscal 2009.
- APTALIS PHARMA INC interest and debt expense for fiscal 2009 was $69.81M.
| Period end | Interest and Debt Expense 3 month | Interest and Debt Expense 6 month | Interest and Debt Expense 9 month | Interest and Debt Expense 12 month |
|---|---|---|---|---|
| 2011-12-31 | $22.10M 10-Q · filed 2012-02-10 | $44.55M derived: sum of 2 quarters · filed 2012-02-10 | $65.22M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2011-09-30 | $22.45M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $43.12M derived: sum of 2 quarters · filed 2011-12-20 | $89.50M 10-K · filed 2011-12-20 | |
| 2011-06-30 | $20.67M 10-Q · filed 2011-08-12 | $67.05M 10-Q · filed 2011-08-12 | ||
| 2010-12-31 | $16.23M 10-Q · filed 2012-02-10 | $32.39M derived: sum of 2 quarters · filed 2012-02-10 | $48.60M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2010-09-30 | $16.16M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $32.37M derived: sum of 2 quarters · filed 2011-12-20 | $64.96M 10-K · filed 2011-12-20 | |
| 2010-06-30 | $16.21M 10-Q · filed 2011-08-12 | $48.79M 10-Q · filed 2011-08-12 | ||
| 2009-09-30 | $69.81M 10-K · filed 2011-12-20 |